Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Endocrinology

• Publication date

  2014-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/cen.12119PMID 23194193
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical practice. Glycemic management of type 2 diabetes mellitus.

  2012cited by this paper
• PANORAMA: a European study to evaluate quality of life and treatment satisfaction in patients with type-2 diabetes mellitus--study design.

  2011cited by this paper
• Engaging and empowering patients to manage their type 2 diabetes, Part II: Initiatives for success

  2010cited by this paper
• Engaging and empowering patients to manage their type 2 diabetes, Part I: a knowledge, attitude, and practice gap?

  2010cited by this paper
• Relationship Between Obesity and Diabetes in a US Adult Population: Findings from the National Health and Nutrition Examination Survey, 1999–2006

  2010cited by this paper
• Changes in glycemic control from 1996 to 2006 among adults with type 2 diabetes: a longitudinal cohort study

  2010cited by this paper
• Evaluation of an Over-the-Counter Glycated Hemoglobin (A1C) Test Kit

  2010cited by this paper
• US Trends in Glycemic Control, Treatment, and Comorbidity Burden in Patients With Diabetes

  2010cited by this paper
• Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix® 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE™ observational study

  2009cited by this paper
• Glucose control and vascular complications in veterans with type 2 diabetes.

  2009cited by this paper
• Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.

  2009cited by this paper
• Trends in the prescription of anti‐diabetic medications in the United Kingdom: a population‐based analysis

  2009cited by this paper
• Overcoming obstacles to effective care of type 2 diabetes.

  2009cited by this paper
• Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy

  2009cited by this paper
• In Germany diabetic patients with coronary artery disease are treated more intensively than diabetic patients with other manifestations of atherothrombosis--results from the REACH registry.

  2009cited by this paper
• Multifaceted Determinants for Achieving Glycemic Control

  2009cited by this paper
• Effects of Intensive Glucose Lowering in Type 2 Diabetes

  2009cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• French medical practice in type 2 diabetes: the need for better control of cardiovascular risk factors.

  2008cited by this paper
• The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review.

  2008cited by this paper
• Advances in Hemoglobin A1c Point of Care Technology

  2007cited by this paper
• Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes.

  2007cited by this paper
• Clinical Predictors of Disease Progression and Medication Initiation in Untreated Patients with Type 2 Diabetes and A 1 C < 7 %

  2007cited by this paper
• Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force.

  2007cited by this paper
• BMC Family Practice BioMed Central Study protocol Patient Engagement and Coaching for Health: The PEACH study –

  2007cited by this paper
• Contributions of β-Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

  2006cited by this paper
• Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control.

  2006cited by this paper
• Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose.

  2006cited by this paper
• Predictors of glycemic control among patients with Type 2 diabetes: A longitudinal study

  2005cited by this paper
• Clinical Inertia Contributes to Poor Diabetes Control in a Primary Care Setting

  2005cited by this paper
• Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study.

  2005cited by this paper
• Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus.

  2005cited by this paper
• Patterns of prescription of hypoglycaemic drugs in Gran Canaria (Canary islands, Spain) and estimation of the prevalence of diabetes mellitus.

  2005cited by this paper
• Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys

  2004cited by this paper
• Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

  2003cited by this paper
• Evaluation of risk factors for development of complications in Type II diabetes in Europe

  2002cited by this paper
• Utilization of oral hypoglycemic agents in a drug-insured U.S. population.

  2001cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper

• Modern Management of CKM Syndrome: Use of GLP-1 Receptor Agonists in a Multidisciplinary Setting-Expert Group Recommendations from Kuwait.

  2026cites this paper
• Improving medication adherence in type 2 diabetes: strategies for better clinical and economic outcomes

  2025cites this paper
• Analyse phénoménologique de l’expérience vécue du patient ayant un diabète de type 2 et hospitalisé pour déséquilibre glycémique chronique

  2025cites this paper
• Treatment of type 2 diabetes mellitus - a current view of the different drug classes and strategies for their use

  2025cites this paper
• Safety, pharmacokinetics and pharmacodynamics of Efsubaglutide Alfa in healthy participants: A randomised, dose‐escalation phase 1 study

  2025cites this paper
• Clinical Profile and Management of Patients with Newly Diagnosed Type 2 Diabetes Mellitus in Hospital Setting

  2025cites this paper
• Poor Glycemic Control and its Determinants in Patients with Type 2 Diabetes Mellitus Taking Treatment at an Urban Health and Training Center in Goa: A Cross-Sectional Study

  2025cites this paper
• Characteristics and longitudinal clinical outcomes of people with type 2 diabetes in regional areas accessing a tertiary telehealth service: A retrospective cohort study

  2025cites this paper
• Striving for early effective glycaemic and weight management in type 2 diabetes: A narrative review

  2025cites this paper
• Uncontrolled glycemia and the associated factors in Iranian type 2 diabetic patients, North of Iran: Role of self-care and self-efficacy

  2025cites this paper
• Real-world Analysis of Clinical Characteristics and Treatment Patterns in Patients with Type 2 Diabetes in the United Arab Emirates

  2025cites this paper
• Patients with Type 2 Diabetes, Higher Blood Pressure, and Infrequent Fundus Examinations Have a Higher Risk of Sight-Threatening Retinopathy

  2024influential citation
• Poor Glycaemic Control and It’s Risk Factors Among Diabetes Patients in An Urban Area of Western India

  2024cites this paper
• Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group

  2024cites this paper
• Glycemic control and its associated factors among adult diabetic patients in Southern Ethiopia: a cross-sectional study

  2024cites this paper
• Relationship between adherence to oral antidiabetic drugs and control of type 2 diabetes mellitus.

  2024cites this paper
• Exploring disparities: A comparative analysis of insulin-naïve, regular users, and inertia patients among type 2 diabetes mellitus outpatients in India

  2024cites this paper
• Should Glucokinase be Given a Chance in Diabetes Therapeutics? A Clinical-Pharmacological Review of Dorzagliatin and Lessons Learned So Far

  2024cites this paper
• Factors Affecting Glycemic Control in Patients with Type 2 Diabetes in Kalasin Province, Thailand: An Analytical Cross-Sectional Study

  2024cites this paper
• Trajectory of haemoglobin A1c and incidence of cardiovascular disease in patients with type 2 diabetes mellitus

  2024cites this paper
• Therapeutic inertia: a retrospective examination of inpatient management for type 2 diabetes mellitus at a South African regional hospital during a singular hospitalisation

  2024cites this paper
• Adherence and Persistence to Basal Insulin Among People with Type 2 Diabetes in Europe: A Systematic Literature Review and Meta-analysis

  2024cites this paper
• Glycemic control and associated factors among type 2 diabetes mellitus patients: a cross-sectional study of Azar cohort population

  2023cites this paper
• Regional differences in the degree of glycaemic diabetes control in Spain and associated factors. IBERICAN study.

  2023cites this paper
• New Frontiers in Diabetes Care.

  2023cites this paper
• Diabetic peripheral neuropathy is associated with diabetic kidney disease and cardiovascular disease - The Silesia Diabetes-Heart Project.

  2023cites this paper
• Effectiveness of Family-Based Diabetes Management Intervention on Glycated Haemoglobin Among Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2023cites this paper
• Osteoarthritis and Diabetes: Where Are We and Where Should We Go?

  2023cites this paper
• Glycaemic control and associated factors among patients living with type 2 diabetes in Kinshasa, Democratic Republic of the Congo: a Cross-sectional study

  2023cites this paper
• Effect of variables of sociodemographic on disease management skills on individuals with type 1 and type 2 diabetes receiving insulin therapy

  2023cites this paper
• The effects of economic status on metabolic control in type 2 diabetes mellitus at 10 metabolic management centers in China

  2023cites this paper
• Poor glycaemic control: prevalence, factors and implications for the care of patients with type 2 diabetes in Kinshasa, Democratic Republic of the Congo: a cross-sectional study

  2023cites this paper
• Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes

  2023cites this paper
• IN THIS ISSUE

  2023cites this paper
• Magnitude and predictors of poor glycemic control in patients with diabetes at Jimma Medical Center, Ethiopia

  2023cites this paper
• New Frontiers in Diabetes Care.

  2023cites this paper
• The Use of Digital Telehealth for the Self-Management of Type 2 Diabetes Patients in Hinds County, Mississippi: A Pilot Study

  2023cites this paper
• A retrospective comparison between intensive and nonintensive insulin regimens in type 2 diabetes mellitus

  2023cites this paper
• Diferencias regionales en el grado de control glucémico de la diabetes en España y factores asociados. Estudio IBERICAN

  2022cites this paper
• Toward a new model for the management of type 2 diabetes: The mountain is there and there is no other option than to climb it.

  2022cites this paper
• Determinants of glycemic control in type 2 diabetes mellitus in Brazil: A sub-analysis of the longitudinal data from the BrazIian type 1 & 2 diabetes disease registry (BINDER).

  2022cites this paper
• Role of therapeutic inertia in glycemic control according to individualized objectives in a cohort of patients with type 2 diabetes. Results from CONCARDIA2.

  2022cites this paper
• The role of Recent Pharmacotherapeutic Options on the Management of Treatment Resistant Type 2 Diabetes

  2022cites this paper
• Durable Metabolic Improvements 2 Years After Duodenal Mucosal Resurfacing (DMR) in Patients With Type 2 Diabetes (REVITA-1 Study).

  2022cites this paper
• Safe use of sodium glucose co-transporter 2 inhibitors in the management of type 2 diabetes.

  2022cites this paper
• Clinical and Genetic Predictors of Glycemic Control and Weight Loss Response to Liraglutide in Patients with Type 2 Diabetes

  2022cites this paper
• Review on sodium glucose co-transporter-2 inhibitors for treatment of type-2 diabetes mellitus

  2022cites this paper
• Glycaemic control among type 2 diabetes patients in sub-Saharan Africa from 2012 to 2022: a systematic review and meta-analysis

  2022cites this paper
• Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER Study

  2022cites this paper
• Epidemiology of Poor Glycaemic Control among Patients with Type 2 Diabetes Mellitus in Terengganu State of Malaysia

  2022cites this paper
• Glycemic control and its determinants among people with type 2 diabetes mellitus in Ernakulam district, Kerala

  2022cites this paper
• Effectiveness and safety of dapagliflozin in real-life patients: data from the DAPA-RWE Spanish multicentre study

  2022cites this paper
• Knocking on GDF15's door for the treatment of type 2 diabetes mellitus.

  2022cites this paper
• The effect of comorbidities on glycemic control among Colombian adults with diabetes mellitus: a longitudinal approach with real-world data

  2021cites this paper
• The Effectiveness of Enhanced Primary Healthcare (EnPHC) interventions on Type 2 diabetes management in Malaysia: Difference-in-differences (DID) analysis.

  2021cites this paper
• Patterns of diabetes management in South Africa: baseline and 24-month data from the South African cohort of the DISCOVER study

  2021cites this paper
• DAPA-RWE: a retrospective multicenter study comparing dapagliflozin and sitagliptin in patients with Type 2 diabetes treated under routine clinical practice in Spain.

  2021cites this paper
• Anti-diabetes Research in India: Contributions from Industrial Organizations

  2021cites this paper
• Prevalence of Complications of Diabetes and Risk Factors Among Patients with Diabetes in the Diabetes Clinic in Southeast of Iran

  2021cites this paper
• Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review

  2021cites this paper
• Evaluating the quality of care for patients with type 2 diabetes mellitus based on the HbA1c: A national survey in Iran

  2021cites this paper
• A retrospective comparison between intensive and non-intensive insulin regimens in type 2 diabetes mellitus.

  2021cites this paper
• Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial

  2021cites this paper
• The economic burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in Denmark

  2021cites this paper
• Variation in hypoglycemia ascertainment and report in type 2 diabetes observational studies: a meta-epidemiological study

  2021cites this paper
• Barriers to Diabetes Self-Management in a Subset of New Zealand Adults with Type 2 Diabetes and Poor Glycaemic Control

  2021cites this paper
• Insulin Management of Patients with Inadequately Controlled Type 2 Diabetes Admitted to Hospital: Titration Patterns and Frequency of Hypoglycemia as Results of a Prospective Observational Study (Hospital Study)

  2021cites this paper
• Trends in glycaemic control and drug use in males and females with type 2 diabetes: Results of the Australian National Diabetes Audit from 2013 to 2019

  2021cites this paper
• Inercia terapéutica en el control glucémico según objetivos individualizados en una cohorte de pacientes con diabetes de tipo 2: resultados del estudio CONCARDIA2

  2021cites this paper
• Factors Associated with Poor Glycemic Control Amongst Rural Residents with Diabetes in Korea

  2021cites this paper
• Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents.

  2021cites this paper
• Evaluation of Medical Care for Diabetic and Hypertensive Patients in Primary Care in Mexico: Observational Retrospective Study

  2021cites this paper
• Adherence to the National Guidelines for Follow-Up Protocol in Subjects with Type 2 Diabetes Mellitus in Greece: The GLANCE Study

  2020cites this paper
• In guidelines physicians trust? Physician perspective on adherence to medical guidelines for type 2 diabetes mellitus

  2020cites this paper
• Relationship between Lipid Profiles and Glycemic Control Among Patients with Type 2 Diabetes in Qingdao, China

  2020cites this paper
• Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: An East Asian perspective

  2020cites this paper
• Poor Glycemic Control: Prevalence and Risk Factors Among Patients with Type 2 Diabetes Mellitus in Northeast State of Peninsular Malaysia

  2020cites this paper
• Organisational and individual characteristics associated with glycaemic control among patients with type 2 diabetes: cross-sectional study in China

  2020cites this paper
• Impact of Quality Improvement (QI) Program on 5-Year Risk of Diabetes-Related Complications: A Simulation Study

  2020cites this paper
• Profile and factors associated with glycaemic control of patients with type 2 diabetes in Greece: results from the diabetes registry

  2020cites this paper
• Clinical inertia is the enemy of therapeutic success in the management of diabetes and its complications: a narrative literature review

  2020cites this paper
• Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK

  2020influential citation
• Should we care to adhere? Guideline adherence rates, glycemic control and physician perspective on adherence for type-2 diabetes

  2020cites this paper
• The burden of type 2 diabetes in Europe: current and future aspects of insulin treatment from patient and healthcare spending perspectives.

  2020cites this paper
• The Relationship Between Diabetes Self-Management and Blood Glucose Control in Patients With Type 2 Diabetes Mellitus in Ulee Kareng Subdistrict, Banda Aceh

  2020cites this paper
• Clinical characteristics and determinants of glycaemic control among type 2 diabetes mellitus (T2DM) patients in Fiji

  2020cites this paper
• Costs of COVID-19 pandemic associated with diabetes in Europe: a health care cost model

  2020cites this paper
• Pharmacokinetics, Safety and Tolerability of Once-Weekly Subcutaneous Semaglutide in Healthy Chinese Subjects: A Double-Blind, Phase 1, Randomized Controlled Trial

  2020cites this paper
• Evaluating the User Preference and Level of Insulin Self-Administration Adherence in Young Patients With Type 1 Diabetes: Experience With Two Insulin Pen Needle Lengths

  2020cites this paper
• Evaluating the Evidence behind the Novel Strategy of Early Combination from Vision to Implementation

  2020cites this paper
• Early Combination Therapy with Linagliptin and Metformin in People with Type 2 Diabetes Improves Glycemic Control to HbA1c ≤ 6.5% without Increasing Hypoglycemia: Pooled Analysis of Two Randomized Clinical Trials

  2020cites this paper
• Evaluating the User Preference and Level of Insulin Self-Administration Adherence in Young Patients With Type 1 Diabetes: Experience With Two Insulin Pen Needle Lengths.

  2020cites this paper
• Type 2 diabetes – unmet need, unresolved pathogenesis, mTORC1-centric paradigm

  2020cites this paper
• Real-World Adequacy of Glycaemic Control in Treatment-Naïve Greek Patients with Type 2 Diabetes Mellitus Initiating Treatment with Metformin Monotherapy at the Maximum Tolerated Dose: The Reload Study.

  2020cites this paper
• Quality performance and associated factors in Swiss diabetes care – A cross-sectional study

  2020cites this paper
• Glycated Hemoglobin Level Goal Achievement in Adults With Type 2 Diabetes in Canada: Still Room for Improvement.

  2019cites this paper
• Physician experiences when discussing the need for additional oral medication with type 2 diabetes patients: Insights from the cross-national IntroDia® study.

  2019cites this paper
• PPA_A_198908 1303..1310

  2019cites this paper
• Prevalence of diabetes, use of antidiabetic drugs and degree of glycaemic control in the province of Cadiz (2014-2016): A population-based study.

  2019cites this paper
• Challenges and factors associated with poor glycemic control among type 2 diabetes mellitus patients at Nekemte referral hospital, western Ethiopia: cross-sectional study

  2019cites this paper